(A) Western blot and densitometry of pNK cells (1x106 cells), alone or co-cultured with 1x106 cells bacteria for either 4 or 6 h. Blotted using (1:1000) mouse antibodies specific for human GrzmH. Rabbit antibody specific for human beta actin antibody was used as a loading control. Intracellular GrzmH levels were normalized to beta actin for densitometry. (B) Western blot analysis of pNK cells (1x106 cells), alone or co-cultured with 1x105 PAO1 for 6 h. PAO1 was isolated from the co-culture using a series of centrifugation and washes with sterile distilled water to form a bacterial pellet which was lysed with 2x Sample Buffer and then boiled. Blotted using (1:1000) mouse antibodies specific for human GrzmH. Rabbit antibody specific for human beta actin and a rabbit antibody specific was E. coli RNA polymerase were used as loading controls for the pNK and PAO1 cells respectively. (C) Western blot and densitometry of YT cells (5x105 cells), alone or cultured with 4x105 PAO1 for 6 h. Blotted using (1:1000) mouse antibodies specific for human Grzm H. Rabbit antibody specific for human beta actin antibody was used as a loading control. Intracellular GrzmH levels were normalized to beta actin for densitometry. (D) Western blot analysis of wild type or GrzmH KO YT cells (human leukemia NK cell line) (5x105 cells) and blotted using (1:1000) mouse monoclonal antibodies specific for human GrzmH (4G5). Rabbit antibody specific for human beta actin antibody was used as a loading control. (E) PAO1 incubated alone or in the presence of wild type or GrzmH knockout YT cells and cultured for 6 h, then plated for CFU counts. Conditions were carried out in n = 4 wells (mean ± SEM) and the graph is representative of n ≥ 3 biological replicates * = P≤0.05, ** = P≤0.01, *** = P≤0.001.